TP53 and breast carcinoma: Increasing evidence suggests that the loss of tumor suppressors, such as p53 and BRCA, and the overexpression of oncogenes, such as MDM2 and NFAT1, play important roles in the progression of breast cancer to advanced disease [11-18].